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The activity of Ca/Mg-dependent endonuelease (CME) is strongly inhibited in mycloma X-63.Agg.653 and B-hybridoma MLC-Ic as compared 
with mouse splenocytes. Nevertheless, pronounced internu¢leo~omal chromatin degradation oecur~ in both cell lines during long-term cultivation 
without passing. In isolated cell nuclei of X-63 the activation of CM E, which precedes chromatin fra~nentation in vivo and loss of cell viability, 
is revealed. The time--course of CME activation is opposite to cell proliferation and is not accompanied by alterations inenzyme quantity. The 
results uggest that cell death of X-63 and MLC-lc occurs via apoptosis0 and involves the mechanisms controlling the activation and/or interaction 
of CME with chromatin. 
Hybridoma; Apoptosis; Ca/Me-dependent endonuclcase 
1. INTRODUCTION 
Apoptosis, or programmed cell death, has been 
widely discussed in the last few years [1]: it seems to be 
a common form of cell death during normal develop- 
ment and a cellular response to various factors [2,3]. 
The biochemical hall-mark of apoptosis i intcrnucleo- 
somal chromatin fragmentation leading to a specific 
ladder of mononucleosomes and their oligomers [4]. 
This process has been described for various types of 
lymphoeytes, hemopoietic precursors and T-hybrido- 
mas, and has been suggested for the activation of nu- 
clear endonuelease(s) and/or alteration of their interac- 
tions with chromatin [5-7]. In this paper we show thaL 
in myeloma X-53 and B-hybridoma MLC-lc cells, in- 
ternucleosomal chromatin degradation occurs during 
maintenance without medium replacement. In X-63 this 
process is accompanied by activation of chromatin 
cleavage in cell nuclei by Ca/Me-dependent endontt- 
clease (CME), but not by acid DNAse. The amount of 
enzyme in cell nuclei remains constant during myeloma 
maintenance. It is believed that mechanisms controlling 
CME interaction with ehromatin may be the critical 
point in apoptotic induction. 
2. MATERIALS AND METHODS 
2.1. Cell ltne,~ at:d ctnintals 
Mouse myeloma :X-63. Ag8.653 and hybridoma MLC-Ic cells were 
Correspondence ad~lress: I.A. tlokolova, National RL~seareh Center of 
Medical Genetics, Russian Academy of Medical Science, 1 Moskvo- 
rechie St., 115478 Moscow, Russian Federation. 
grown in Dulbeeeo's modified Eagle's medium containing 15% bovine 
serum albumin (BSA), 44 mM sodium bicarbonate, 25 mM HEPES 
and 100 mg/ml 8entamicin. Cells wet-' ~¢de.d at a concentration cf 10 ° 
cells/ml and were kept at 37'C in 5% CO:/95% air incubator for 12 
days without passing. MLC-Ic was derived by fitsion of X-63 and 
Balb/c mice spleno~tes immunized by light chain 1 of human myosin. 
Cell viability was measured by Trypan blue excision. Proliferation 
assays were perform~ as de~ritxxl in [8]. Balb/c mice were used in 
e~perilnents for isolation of splenoeyte cell nuclei. 
2.2. Activation arm nwasurement of endonucleases in cell nuclei 
Isolation of cell nuclei wa~ p~rform~ d~ribed in [9] with slip~ht 
modifications. The nuclei were transferred in 50 mM Tris-HCl, pH 
8.0, 10 mM MgCI,, 1 mM CaCI.~, 0.25 M sucrose for activation of 
CM E, or 50 m M sodium acetate, pH 4.8, 1 mM Na_,EDTA for activa- 
tion of acid DNAse, and incubated for I h at 37"C. Nuclei were ly~d 
in 1 M NaCl, 0,5% $DS, incubated with RNA~ A (209 mg/ml) for 
1 h at 37°C, proteinase K (50 mg/ml) for 1 h at 37*C, and twice 
deproteinized with chloroform/isoamyl alcohol (24:1). DNA was ~p- 
arated electrophoretically in 1.2% agaro~ gels. DNA was visualized 
by staining with ¢thidium bromide~ photographed in UV light and 
negatives were scanned on an Ultrosean XL densitometer. The nuclear 
endonuclease activity was measu 'red according to [10]. 
2.3. bnmunochentieal attalysis of CME in isolated cell nuclei 
ELISA wa~ carried out with the monoelonal ntibody, DN [11]. 
95-well microplates were coated with nuclear extract (10 mg/ml) pre- 
pared as described in [i 1], incubated with I% BSA, washed and incu- 
bated with antibody DN dilated in 0.01 M phosphate buffer, pH 7.5 
containing 0.015 M NaCI (1:1,000), then with biotinylated goat anti- 
mouse antibodies followed by streptavidin-biotinylated horse-radish 
peroxidase complex (Amersham, UK), o-Phenylenediamine-H:O: 
was used a.. the peroxida~e substrate. 
3. RESULTS 
Fig. l demonstrates the comparative activity of CME 
in isolated nuclei of mouse splenoeytes and 3-day cul- 
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tures of myeloma nd hybridoma cells. CME is easily 
activated in splenocyte cell nuclei, leading to rapid inter- 
nucleosomal chromatin degradation. In contrast, only 
restricted CME activity and no demonstratable pro- 
nounced internucleosomal chromatin degradation, even 
after 2 h incubation, are found in myeloma nd hybrid- 
oma cell nuclei. 
We studied the possibility of CME activation and 
endonuclease(s)-driven chromatin degradation in vivo 
and in vitro during long (up to 10-12 days) maintenance 
of cell lines without medium replacement. The results 
are shown in Figs. 2 and 3. Both cell lines grow in these 
conditions up to the 7-gth day. During the first 6 days 
the cell populations maintain their initial viability, but 
from the 7th day a rapid decrease in viability occurs. 
Fig. 3 shows that loss of viability is accompanied by 
chromatin cleavage in vivo in both cell lines. In MLC-lc 
the pronounced sign of that process is revealed on the 
6th day of cultivation, and from the 7th day the typical 
nucleosomal ladder is observed. In X-63 the bulk of the 
nuclear DNA converted to nucleosomes and their eli- 
comers, also on the 7th day of cultivation, and a differ- 
ent character of DNA cleavage in native and incubated 
myeloma nuclei, was found. We may conclude that 
under the conditions used, the loss of viability of my- 
eloma and hybridoma cells is connected with internucle- 
osomal chromatin degradation. We examined the acti- 
vation of CME in isolated cell nuclei of both cell lines 
in the time-course of their cultivation. No enzyme acti- 
vation was observed in isolated nuclei of B-hybridoma 
MLC-lc cells, even though there was pronounced DNA 
degradation i  vivo (Fig. 3B). We were unable to detect 
enzymatic activity in isolated cell ~uclei of hybridoma 
ceils, although using the monoclonal antibody, DN, to 
CME we detected the specific protein in extracts, and 
no significant change of CME content was found. 
The pronounced increase in enzyme activity is ob- 
served in X-63 from the 4th day (Figs. 3A and 2C). Up 
to the 6th day it reaches an almost maximum level, while 
only from that day onwards is the decrease incell viabil- 
ity observed (Fig. 2B). So, in myeloma cells, CME acti- 
vation precedes cell death and detectable DNA frag- 
mentation in vivo. Immunochemical estimation of the 
CME amount in extracts did not reveal parallel changes 
in the specific protein content (Fig. 2C). 
As can be seen in Fig. 2D, a drastic decrease in pro- 
liferative activity in X-63 occurs beginning from the 4th 
day. It is interesting that the time-course of relative 
proliferative activity (defined as the total proliferation 
divided by the amount of viable cells) is equal to the 
time--course of total proliferation. This indicates that 
there is a uniform decrease in proliferation activity of 
viable cells in the culture. It is known that some types 
of acid DNAses can exist in cell nuclei [!2]. We meas- 
ured CME and acid DNAse activity in isolated nuclei 
of X-63 from 5-day cultures The activity of acid 
DNAse was very low (5 U) as compared with CME 
1 2 3 4 5 6 7 8 9 10 11 12 13 
Fig. 1. CME activation i isolate! ~11 nuclei of myeloma X-63. 
A88.653 (lanes 1-4), hybrldoma MLC-le (lanes 5-8) and Balb/¢ sple- 
noeytes (lanes 9-13). Cells were harvested onthe third day of cultiva- 
tion. Time of incubation: 15min, lane 10; 30 rain, lanes 2,6,11; 60 min, 
lanes 3,7,12; 120 rain, lanes 4,8,13. Control, anes 1~5,9. 
activity (43 U). Even with longer incubations of my- 
eloma nuclei n buffer medium for acid DNAse we did 
not observe internucleosomal fragmentation fchroma- 
tin. 
4. DISCUSSION 
The obtained results show that CME activity in nu- 
clei ofmyeloma X-63 cells is not detectable, the opposite 
situation to that observed in Balb/c splenocyte nuclei in 
which CME is easily activated and cleaves chromatin 
DNA. In MLC-lc, which is a nybrid of X-63 and sple- 
nocytes, the enzyme activity and its interaction with 
ohromatin are similar to the myeloma co!Is and not to 
the splenocytes. So the tumor, hybrid cells demonstrate 
restricted CME activity and/or its interaction with chro- 
matin in isolated cell nuclei as compared with sple- 
nocytes. 
Long-term cultivation of both hybridoma and my- 
eloma cell lines leads to the internucleosomal fragmen- 
tation, which is one of the main biochemical signs of 
apoptosis or programmed cell death [4,6]. The induc- 
tion of apoptosis can be achieved by the appearance or
disappearance of necessary factors, for example difl'er- 
ent interleukins [1,6], but the secretion of some specific 
factor(s) during long-term cultivation of X-63 and 
MLC-lc cannot be excluded. Analogous results were 
obtained for B-hybridoma ceils set up in protein-free 
medium [13]. 
CME activation in X-63 cell nuclei precedes internu- 
cleosomal chromn_.tin degradation in cultivated cells. 
This result is similar to some reported cases of CME 
activation as one of the early events of cell death [4,14]. 
It should be noted that the time-course of CME activa- 
tion is opposite to that of proliferative activity. Proba- 
bly, the mechanisms which stimulate cell proliferation 
lead to inhibition of CME and/or estriction of its inter- 
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Fig, 2. Characteristics ofcell growth, proliferation and CME changes during euhivation of myeloma X-63.Agg.653 andhybridoma MLC-Ie. (A) 
Cell growth, (B) cell viability and (C) CME changes during cultivation of X-63 (line 1, O, enzyme activity in isolated cell nuclei; line 2, A enzyme 
content in nuclear extracts by ELISA with monoclonal ntibody DN according to section 2. (D) Proliferation activity of X63 line 1, O, total ~H 
incorporation; line 2, [~, relative ~H incorporation (~ee section 2). 
actions with chromatin [7,15]. We observed a similar 
situation in nuclei of peripheral blood lymphocytes dur- 
ing chronic lympholeueosis [16]; in this ease the specific 
protein inhibitor was revealed. The results uggest that, 
in the cells studied, the regulation of the enzyme is not 
achieved through de novo CME synthesis and/or its 
transport into the nuclei, but realized through another 
mechanism [17]. 
During the later stages of cultivation deep fragmenta- 
tion of nuclear DNA is achieved both in X-63 and in 
MLC-lc when most of the chromatin is converted to 
m,~n,~ . . . .  1~,~,~ tr:;,, 3). This wo-ld be possible only 
when CME is presented in tile nuclei in th~ fr~ form 
(not bound to chromatin) and every linker ~egtaent is 
accessible to the enzyme. However, biochemical e;4- 
dence has shown that the enzyme is bound to ehromatin 
and can only be elated with salt [18]. 
A lot of information devoted to the high order struc- 
ture ofehromatin, which determines non-random acces- 
sibility of its different regions to endonucleases, has 
accumulated [19]. This finds that both factors must un- 
dergo alterations during the early steps of apoptotie 
induction - -  the enzyme fixation in ¢hromatin and the 
chromatin structure itself. These pro~sses eems to be 
critical points in understanding the role of CME and 
other endonueleases in apoptotie induction, and are the 
aims of our further investigations. 
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Fig. 3. Chromatin degradation i vivo and in vitro during cultivation of X-63 (A) and MLC-ie (A). For each day of cultivation a means DNA 
extracted from native isolated nuclei and b means DNA from isolated nuclei, incubated for 1 h in bulTe,, medium for CME activation (see [8]). 
Arrows indicate the position of molecular size markers (Hindlll digest of A..DNA). 
298 
Volume 313, number 3 FEBS LETTERS November 1992 
REFERENCES 
[ 1] Tomei, L.D. and Cope, F.O. (1991 )in: Apoptosis: The Molecular 
Basis of Cell Death, Cold Spring Harbour Laboratory Press, NY. 
[2] McCall, C.A, and Cohen, J..l. (1991) .It. Invest. Dermatol. 97, 
111-114. 
[3] Eastman, A. (1990) Cancer Cell 2, 275-280. 
[4] Wyllie, A.H. (1980) Nature 284, 555-556. 
[5] Shi, Y., Szalay, M., Pa.~kar, I.., Boyer, M., Sine.h, B. and Green, 
D.R. (1990) J. [mmunol. 144, 3326-3335. 
[6] Williams, G.T. (1991) Cell 65, 1097--1098. 
[7] Cohen, J.J. and Duke, R.C. (1984) J. lmmtmol. 132, 38-.42. 
[8] Schmidt, J.A., Bomford, R., Gao, X.M. and Rhodes. J. (1990) 
Int. J. lmmu1:opharmagol. 12,89-97. 
[9] Agutter, P.S. (1972) Biochim. Biophys. Acta 255, 397--401. 
[10] Tkaeheva, T.I., Kirson, S.S., Khodarev, N.N. and Votrin, 1.1. 
(1990) Bull. Exp. Biol. Med. (USSR) 109, 543-546. 
[11] Volgina, V.V., Khodarev, N.N., Volgin, A.U., Votrin, 1.I. and 
Pgvnitsky, L.A. (1988) Bull. Exp. Biol. Med. (USSR) 105, 419- 
421. 
[12] Nagae, $., Ikc~la, M. and Anai, M. (1983) Biogh,'m. Biophys. 
Res, Comman, I16, 952-961. 
[13] Franek, F. and Dolnikova, J. (1991) FEBS Lett. 284, 285-287. 
[14] Compton, M.M. and Cidlowsky, LA. (1987) J. Biol. Chem. 262, 
8288-8292, 
[15] Hewish, D,R. and Burgoyne, L.A. (1973)Biochem. Biophys. ges. 
Commun. 52, 504-510. 
[16] Khodarev, N.N., ivanova, T.N. and Votrin, 1.1. (1983) Dokl. 
Aeademii Nauk (USSR) 268, 1000-1003. 
[17] Gaido, M.L. and Cidlowsky, LA. (1991) J. Biol. Chem. 266, 
18580-18585. 
[18] lshida, R., Akiyoshi, H. and Takahoshi, T. (1974) Biochem. Bio- 
phys. Res. Commun. 56, 703-710. 
[19] Eissenbery, J.C., Cartwright, I.L., Thomas, G.H. and EIsin, 
S.C.R. (1985) Anntt. Rev. Genet. 19, 485-536. 
299 
